Fondaparinux Subcutaneous and Nevirapine Extended-Release Tablets
Determining the interaction of Fondaparinux Subcutaneous and Nevirapine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fondaparinux
Brand name: Arixtra, Arixtra 5 mg/dose, Arixtra 75 mg/dose, Arixtra 10 mg/dose
Synonyms: Fondaparinux
Generic Name: nevirapine
Brand name: Viramune, Viramune XR
Synonyms: Nevirapine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fondaparinux Subcutaneous-Nevirapine Oral Suspension
- Fondaparinux Subcutaneous-Nevirapine Suspension
- Fondaparinux Subcutaneous-Nevirapine Tablets
- Fondaparinux Subcutaneous-New Day
- Fondaparinux Subcutaneous-New Terocin
- Fondaparinux Subcutaneous-Nexa Plus
- Nevirapine Extended-Release Tablets-Foradil
- Nevirapine Extended-Release Tablets-Foradil Aerolizer
- Nevirapine Extended-Release Tablets-Forane
- Nevirapine Extended-Release Tablets-Forfivo XL
- Nevirapine Extended-Release Tablets-Formerly available as Dalmane
- Nevirapine Extended-Release Tablets-Formerly available as Librium